Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Gyorgy Bodoky

Oxaliplatin Plus Irinotecan Compared With Irinotecan Alone as Second-Line Treatment After Single-Agent Fluoropyrimidine Therapy for Metastatic Colorectal Carcinoma

Journal of Clinical Oncology

English

Related publications

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Journal of IMAB - Annual Proceeding (Scientific Papers)

Dentistry

2011

English

Reply: Oxaliplatin- Or Irinotecan-Based Chemotherapy for Metastatic Colorectal Cancer in the Elderly

British Journal of Cancer

Cancer Research

Oncology

2004

English

U.S. Food and Drug Administration Approval: Panitumumab for Epidermal Growth Factor Receptor-Expressing Metastatic Colorectal Carcinoma With Progression Following Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Containing Chemotherapy Regimens

Clinical Cancer Research

Cancer Research

Oncology

2008

English

5 Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) as a Third-Line Chemotherapy Treatment in Metastatic Gastric Cancer, After Failure of Fluoropyrimidine, Platinum, Anthracycline, and Taxane

Bosnian Journal of Basic Medical Sciences

Medicine

2017

English

Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-Line Treatment for Patients With Recurrent or Metastatic Biliary Tract Cancer

Cancer Research and Treatment

Cancer Research

Oncology

2018

English

Cetuximab Plus Irinotecan Versus Panitumumab in Patients With Refractory Metastatic Colorectal Cancer in Ontario, Canada

International Journal of Cancer

Cancer Research

Oncology

2017

English

Capecitabine Plus Oxaliplatin Compared With 5-Fluorouracil Plus Oxaliplatin in Metastatic Colorectal Cancer: Meta-Analysis of Randomized Controlled Trials

English

Cetuximab and Irinotecan as Third-Line Therapy in Advanced Colorectal Cancer Patients: A Single Centre Phase II Trial

British Journal of Cancer

Cancer Research

Oncology

2006

English

Second-Line Chemotherapy for Refractory Small Cell Neuroendocrine Carcinoma of the Esophagus That Relapsed After Complete Remission With Irinotecan Plus Cisplatin Therapy: Case Report and Review of the Literature

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Gyorgy Bodoky

Oxaliplatin Plus Irinotecan Compared With Irinotecan Alone as Second-Line Treatment After Single-Agent Fluoropyrimidine Therapy for Metastatic Colorectal Carcinoma

Related publications

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Reply: Oxaliplatin- Or Irinotecan-Based Chemotherapy for Metastatic Colorectal Cancer in the Elderly

U.S. Food and Drug Administration Approval: Panitumumab for Epidermal Growth Factor Receptor-Expressing Metastatic Colorectal Carcinoma With Progression Following Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Containing Chemotherapy Regimens

5 Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) as a Third-Line Chemotherapy Treatment in Metastatic Gastric Cancer, After Failure of Fluoropyrimidine, Platinum, Anthracycline, and Taxane

Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-Line Treatment for Patients With Recurrent or Metastatic Biliary Tract Cancer

Cetuximab Plus Irinotecan Versus Panitumumab in Patients With Refractory Metastatic Colorectal Cancer in Ontario, Canada

Capecitabine Plus Oxaliplatin Compared With 5-Fluorouracil Plus Oxaliplatin in Metastatic Colorectal Cancer: Meta-Analysis of Randomized Controlled Trials

Cetuximab and Irinotecan as Third-Line Therapy in Advanced Colorectal Cancer Patients: A Single Centre Phase II Trial

Second-Line Chemotherapy for Refractory Small Cell Neuroendocrine Carcinoma of the Esophagus That Relapsed After Complete Remission With Irinotecan Plus Cisplatin Therapy: Case Report and Review of the Literature